MedPath

Rehabilitation through exercise prescription for cardiac patients using an artificial intelligence-based programme - RECAP

Not Applicable
Conditions
Service users requiring cardiac rehabilitation
Not Applicable
Registration Number
ISRCTN97352737
Lead Sponsor
South Tees Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients eligible for cardiac rehabilitation

Exclusion Criteria

1. Awaiting urgent surgery
2. Unstable angina
3. Pregnancy
4. Currently enrolled in another interventional clinical trial or experiment
5. Malignant arrhythmias
6. Contraindications to rehabilitation - e.g.
6.1. Severe musculoskeletal conditions affecting exercise ability
6.2. Acute systemic illness or fever
6.3. Acute pericarditis or myocarditis
6.4. Uncontrolled atrial or ventricular arrhythmias
6.5. Uncontrolled sinus tachycardia
6.6. Aortic stenosis associated with pre-syncope/syncope
6.7. Uncompensated Heart failure
6.8. Complete atrioventricular block without a pacemaker
6.9. Recent embolism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of conducting a large-scale randomised controlled trial measured using participant recruitment and dropout rates, acceptability of the intervention and the feasibility of randomisation at 12 weeks
Secondary Outcome Measures
NameTimeMethod
<br> 1. Aerobic capacity and endurance measured using the 6-minute walk test at baseline and 8 weeks<br> 2. Health-related quality of life measured using EQ-5D-5L questionnaire at baseline and 8 weeks<br> 3. Health-related quality of life measured using SF-36 questionnaire at baseline and 8 weeks<br> 4. Anxiety and depression assessed using HADS questionnaire at baseline and 8 weeks<br> 5. Impact on quality of life measured using PROM-CR questionnaire at 8 weeks<br> 6. Performance in activities of daily living measured using Barthel Index questionnaire at baseline and 8 weeks<br> 7. Adherence to the intervention, including usage of the app measured using app s at 8 weeks<br>
© Copyright 2025. All Rights Reserved by MedPath